【HanKang Biotech】2026 Q1 EPS reported at -2.10 TWD
HanKang Biotech (7827), a Cayman Islands-based company, announced its financial results for the first quarter of 2026, reporting an EPS of -2.10 TWD, revenue of 0.00 billion TWD, and a net loss of 330 million TWD.
📋 Article Processing Timeline
- 📰 Published: March 1, 2026 at 09:00
- 🔍 Collected: May 30, 2026 at 08:00 (2159h 0m after Published)
- 🤖 AI Analyzed: June 1, 2026 at 23:35 (63h 35m after Collected)
Company Code: 7827. Company Name: HanKang Biotech (Cayman Islands). Industry: Biotechnology and Medical. Period: 2026 Q1. Basic EPS: -2.10 TWD. Operating Revenue: 0.00 billion TWD. Net Profit after tax: -330 million TWD.
FAQ
How is the performance of HanKang Biotech?
The company reported a loss in Q1 2026 with an EPS of -2.10 TWD.